help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visakorpi, T.
Right arrow Articles by Kallioniemi, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visakorpi, T.
Right arrow Articles by Kallioniemi, O. P.

American Journal of Pathology, Vol 145, 624-630, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization

T Visakorpi, E Hyytinen, A Kallioniemi, J Isola and OP Kallioniemi
Department of Clinical Chemistry, Tampere University Hospital, Finland.

The pattern of chromosomal aberrations and their significance in prostate cancer are poorly understood. We studied 23 prostate cancer and 10 benign prostatic hyperplasia (BPH) specimens by fluorescence in situ hybridization (FISH) using pericentromeric repeat-specific probes for 10 different chromosomes. The aims of the study were: 1) to compare the sensitivity of FISH and DNA flow cytometry in aneuploidy detection, 2) to determine which chromosome copy number changes are most common, and 3) which probe combinations would be most effective in aneuploidy diagnosis. Disaggregated tumor cells from formalin-fixed, paraffin- embedded tissues were pretreated with our newly developed method based on hot glycerol solution to improve probe penetration. All BPH specimens were diploid by DNA flow cytometry and showed no numerical chromosome aberrations by FISH. In prostate cancer, flow cytometry showed abnormal DNA content in 35% of cases, whereas 74% were abnormal by FISH. Aberrant copy number of chromosomes 8 (48% of cases), X (43% of cases), and 7 (39% of cases) were most common. Ninety-four percent of all aneuploid cases would have been detected with these three probes alone. Simple chromosome losses were uncommon but in DNA tetraploid tumors relative losses (trisomy or disomy) of several chromosomes were often found, suggesting progression of prostate cancer through tetraploidization followed by losses of selected chromosomes. In conclusion, our results indicate that FISH using three selected chromosome-specific probes is two to three times more sensitive than flow cytometric DNA content analysis in aneuploidy detection.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Fehm, A. Sagalowsky, E. Clifford, P. Beitsch, H. Saboorian, D. Euhus, S. Meng, L. Morrison, T. Tucker, N. Lane, et al.
Cytogenetic Evidence That Circulating Epithelial Cells in Patients with Carcinoma Are Malignant
Clin. Cancer Res., July 1, 2002; 8(7): 2073 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Ott, J. Kalla, A. Steinhoff, A. Rosenwald, T. Katzenberger, U. Roblick, M. M. Ott, and H. K. Muller-Hermelink
Trisomy 3 Is Not a Common Feature in Malignant Lymphomas of Mucosa-Associated Lymphoid Tissue Type
Am. J. Pathol., September 1, 1998; 153(3): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Am. J. Pathol., July 1, 1998; 153(1): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Ott, J. Kalla, M. M. Ott, B. Schryen, T. Katzenberger, J. G. Muller, and H. K. Muller-Hermelink
Blastoid Variants of Mantle Cell Lymphoma: Frequent bcl-1 Rearrangements at the Major Translocation Cluster Region and Tetraploid Chromosome Clones
Blood, February 15, 1997; 89(4): 1421 - 1429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.